Clavamox and alanine aminotransferase increased 
Clavamox and alanine aminotransferase increased Patient Reports February 12, 2012
Clavamox Side Effects Report #5926618-2
Clavamox side effect was reported by a Physician from JAPAN on Oct 16, 2008. Female patient, child 1 years of age, weighting 22.49 lb, was diagnosed with otitis media and was treated with Clavamox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hepatic function abnormal, liver disorder. Clavamox dosage: 48.2MGK TWICE PER DAY. Patient was hospitalized. Patient recovered.
Clavamox Side Effects Report #5939097-6
Clavamox side effect was reported by a Physician from JAPAN on Oct 28, 2008. Female patient, child 1 years of age, weighting 22.49 lb, was diagnosed with otitis media and was treated with Clavamox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hepatic function abnormal, jaundice
, liver disorder, pyrexia, rash . Clavamox dosage: 48.2MGK TWICE PER DAY. Patient was hospitalized. Patient recovered.Clavamox Side Effects Report #5757060-5
Clavamox side effect was reported by a Physician from AUSTRIA on May 27, 2008. Male patient, 76 years of age, was treated with Clavamox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, helicobacter infection, hepatic failure, hypersensitivity, rash
. Clavamox dosage: unknown. During the same period patient was treated with METRONIDAZOLE, CLARITHROMYCIN, PROTON PUMP INHIBITOR. Patient was hospitalized. Patient died on 05/11/2008.Clavamox Side Effects Report #5742733-0
Clavamox side effect was reported by a Physician from AUSTRIA on May 15, 2008. Male patient was treated with Clavamox. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, helicobacter infection, hepatic failure, hypersensitivity, rash
. Clavamox dosage: unknown. During the same period patient was treated with METRONIDAZOLE, CLARITHROMYCIN, PROTON PUMP INHIBITOR. Patient was hospitalized. Patient recovered.